Impact of the COVID-19 lockdown on diabetes patients in Jeddah, Saudi Arabia

Diabetes Metab Syndr. 2020 Sep-Oct;14(5):1583-1587. doi: 10.1016/j.dsx.2020.07.051. Epub 2020 Aug 12.

Abstract

Aims: To explore the impact of the coronavirus disease lockdown on diabetes patients living in Jeddah, Saudi Arabia, in terms of their compliance with medication intake and lifestyle habits, and quality of life.

Methods: In this cross-sectional, qualitative prospective study, a questionnaire was administered over the telephone to diabetes patients who had attended National Guard primary care centers in Jeddah, Saudi Arabia. The survey included questions on demographic data, type of diabetes, medications used, comorbidities, medication compliance, and daily habits before and after the lockdown, and those assessing patients' psychological parameters during the past month by using the Kessler Psychological Distress Scale (K10). Data analysis was performed using SPSS program version 26.

Results: Totally, 394 patients participated. All of them had type 2 diabetes, and 37.6% had only one comorbidity. Antidiabetic monotherapy was used in 76.4% of the patients, while combination therapy was used in 23.6%. The compliance score before the lockdown was significantly higher (18.49 ± 3.05) than that after it (17.40 ± 3.25) (p-value <0.001). The average psychological assessment score was 9.78 ± 4.14 (range 8-35). Male participants and smokers had a significantly better psychological status than female participants (p-value = 0.002) and non-smokers (p value < 0.001), respectively.

Conclusions: The patients' levels of compliance with medications and healthy lifestyle habits were significantly reduced after the lockdown. These findings highlight the need for healthcare professionals to encourage diabetes patients to adhere to healthy lifestyle habits and use telemedicine during lockdowns to ensure optimal blood glucose control and reduce the incidence of complications.

Keywords: COVID-19; Compliance; Curfew; Diabetes; Lockdown.

MeSH terms

  • Adult
  • COVID-19
  • Coronavirus Infections
  • Cross-Sectional Studies
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Diabetes Mellitus, Type 2 / psychology
  • Female
  • Humans
  • Hypoglycemic Agents / therapeutic use*
  • Life Style
  • Male
  • Medication Adherence / statistics & numerical data*
  • Middle Aged
  • Pandemics
  • Pneumonia, Viral
  • Prospective Studies
  • Qualitative Research
  • Quality of Life
  • Quarantine / psychology*
  • Saudi Arabia
  • Young Adult

Substances

  • Hypoglycemic Agents